Dr. Shashaanka Ashili is a scientist-entrepreneur recognized for his leadership at the intersection of translational medicine, biomedical engineering, and innovation strategy. As the founding CEO of CureScience, he built and led a cross-functional research team focused on advancing personalized immunotherapy solutions in oncology and neurology. He pioneered the Appomics initiative, which continues under his direction, integrating real-time biometric data from devices and health apps to develop AI-based clinical prediction models. Dr. Ashili is also the founder of LongevityAsia, a global conference focused on accelerating research in longevity and quality of life. With graduate degrees in Electrical Engineering (Wright State University) and Optical Science (UNC Charlotte), and a postdoctoral fellowship in surgical innovation at the University of Missouri, he brings deep technical and commercialization expertise. He later served as a research scientist at Arizona State University’s Biodesign Institute under a major NIH grant.